SPRO — Spero Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapTurnaround

Annual balance sheet for Spero Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	82	127	146	109	76.3
Net Total Receivables	8.55	6.18	2.64	1.08	50.7
Prepaid Expenses
Total Current Assets	95.4	139	158	114	131
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.15	8.78	7.56	5.49	4.16
Long Term Notes Receivable
Other Long Term Assets
Total Assets	106	153	171	125	182
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	26.7	14.3	18.7	21.6	37.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31.5	21.4	82.8	48.9	75.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	74.6	132	88.3	75.9	107
Total Liabilities & Shareholders' Equity	106	153	171	125	182
Total Common Shares Outstanding
Total Preferred Shares Outstanding